BB Biotech’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $4.59M | Hold |
416,500
| – | – | 0.12% | 34 |
|
|
2018
Q4 | $15.3M | Hold |
416,500
| – | – | 0.49% | 32 |
|
|
2018
Q3 | $15.7M | Hold |
416,500
| – | – | 0.41% | 29 |
|
|
2018
Q2 | $11.2M | Hold |
416,500
| – | – | 0.32% | 31 |
|
|
2018
Q1 | $17.5M | Hold |
416,500
| – | – | 0.48% | 26 |
|
|
2017
Q4 | $10.3M | Hold |
416,500
| – | – | 0.29% | 29 |
|
|
2017
Q3 | $9.5M | Hold |
416,500
| – | – | 0.26% | 26 |
|
|
2017
Q2 | $9.58M | Hold |
416,500
| – | – | 0.29% | 26 |
|
|
2017
Q1 | $10.7M | Hold |
416,500
| – | – | 0.35% | 26 |
|
|
2016
Q4 | $10.5M | Hold |
416,500
| – | – | 0.39% | 26 |
|
|
2016
Q3 | $17.3M | Hold |
416,500
| – | – | 0.61% | 24 |
|
|
2016
Q2 | $60.6M | Hold |
416,500
| – | – | 2.39% | 15 |
|
|
2016
Q1 | $43M | Hold |
416,500
| – | – | 1.71% | 16 |
|
|
2015
Q4 | $69.9M | Hold |
416,500
| – | – | 1.97% | 14 |
|
|
2015
Q3 | $58.9M | Buy |
416,500
+7,500
| +2% | +$1.06M | 1.87% | 14 |
|
|
2015
Q2 | $91.1M | Sell |
409,000
-13,500
| -3% | -$3.01M | 2.47% | 15 |
|
|
2015
Q1 | $69.9M | Buy |
422,500
+27,500
| +7% | +$4.55M | 2.08% | 18 |
|
|
2014
Q4 | $46.8M | Buy |
395,000
+20,000
| +5% | +$2.37M | 1.52% | 20 |
|
|
2014
Q3 | $31.3M | Buy |
+375,000
| New | +$31.3M | 1.27% | 19 |
|